U.S. Continuous Positive Airway Pressure Devices Market To Reach $2.07 Billion By 2033

U.S. Continuous Positive Airway Pressure Devices Market Growth & Trends

The U.S. continuous positive airway pressure devices market size is expected to reach USD 2.07 billion by 2033, registering a CAGR of 5.50% from 2026 to 2033, according to a new report by Grand View Research, Inc. The market is driven by several factors, including the increasing prevalence of sleep apnea and respiratory conditions, advancements in CPAP device technology, increased awareness and diagnosis of sleep apnea, and supportive reimbursement policies.

Technological advancements represent another crucial driver in the U.S. CPAP market. Continuous innovation has led to the development of more user-friendly, quieter, and compact devices, enhancing patient comfort and compliance. Introducing innovative technologies, such as remote monitoring and connectivity features, allows patients to track their sleep patterns and treatment progress, driving an active role in their healthcare.

Increased awareness campaigns by healthcare organizations and government bodies lead to more individuals seeking diagnosis and treatment for sleep apnea. In addition, favorable reimbursement policies by insurance providers make CPAP therapy more accessible to a broader population segment. Recognizing the long-term benefits of CPAP therapy in preventing complications associated with untreated sleep apnea also encourages healthcare providers to recommend and prescribe these devices frequently.

 Request a free sample copy or view report summary: U.S. Continuous Positive Airway Pressure Devices Market Report

U.S. Continuous Positive Airway Pressure Devices Market Report Highlights

• The connected CPAP devices segment led the market with the largest revenue share of 69.4% in 2025 and is anticipated to grow at the fastest CAGR over the forecast period.

• The non-connected device segment is anticipated to grow at a significant CAGR over the forecast period. This segment is driven by demand from tech-averse users, older adults, and individuals in rural areas with limited internet access.

• The home care settings segment led the market with the largest revenue share of 59.42% in 2025 and is anticipated to grow at the fastest CAGR during the forecast period, driven by increasing preference for at-home treatment of sleep apnea and the growing aging population.

• The hospitals & clinics segment is anticipated to grow at a significant CAGR over the forecast period. These facilities are the first point of contact for patients undergoing sleep studies and receiving prescriptions for CPAP therapy.

U.S. Continuous Positive Airway Pressure Devices Market Segmentation

Grand View Research has segmented the U.S. continuous positive airway pressure devices market on the basis of connectivity and end use:

U.S. Continuous Positive Airway Pressure Devices Connectivity Outlook (Volume, 000' Units; Revenue, USD Million, 2021 - 2033)

• Connected

  • Bluetooth-Connected CPAP

  • Wi-Fi & Cellular Connected CPAP

  • Hybrid-Connected

• Non-Connected

U.S. Continuous Positive Airway Pressure Devices End Use Outlook (Volume, 000' Units; Revenue, USD Million, 2021 - 2033)

• Home Care Settings

• Hospitals & Clinics

• Others (Long-Term Care Facilities, etc.)

List of Key Players in the U.S. Continuous Positive Airway Pressure Devices Market

• ResMed

• Koninklijke Philips N.V.

• Fisher & Paykel Healthcare Limited

• React Health (3B Medical)

• Löwenstein Medical

• BMC Medical

• Wellell (Apex Medical)

• Armstrong Medical

• Breas Medical

• SEFAM

• Transcend Inc. (Somnetics International, Inc.)

• Trudell Medical (Vyaire)

• Medical Depot, Inc. dba Drive DeVilbiss Healthcare

• Invacare Corporation

• Apria Healthcare Group LLC

• Rotech Healthcare Inc.

U.S. PAP Device DME Distributor-Level Profiles

• Lincare Holdings Inc.

• Rotech Healthcare Inc.

• adaptHealth

• Aeroflow Health

• CPAP.com

• AHOM

• The CPAP Shop

• Sleep Direct

• Edgepark Medical Supplies

• Apria Healthcare